HumalogMix75/25 (Eli Lilly and Company)
Welcome to the PulseAid listing for the Humalog drug offered from Eli Lilly and Company. This Insulin [Chemical/Ingredient],Insulin Analog [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Eli Lilly and Company |
| NON-PROPRIETARY NAME: | Insulin lispro |
| SUBSTANCE NAME: | INSULIN LISPRO |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Insulin [Chemical/Ingredient],Insulin Analog [EPC] |
| ROUTE: | SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, SUSPENSION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1999-12-22 |
| END MARKETING DATE: | 0000-00-00 |
Humalog Mix75/25 HUMAN PRESCRIPTION DRUG Details:
| Item Description | Humalog Mix75/25 from Eli Lilly and Company |
| LABELER NAME: | Eli Lilly and Company |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100([iU]/mL) |
| START MARKETING DATE: | 1999-12-22 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0002-7511_ddb5903e-0eb4-4147-8a1b-afdae83f155f |
| PRODUCT NDC: | 0002-7511 |
| APPLICATION NUMBER: | NDA021017 |
Other INSULIN LISPRO Pharmaceutical Manufacturers / Labelers:
